Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Determination of ANA specificity using the UltraPlex platform.

Jodie Smith1, David Onley, Caroline Garey

  • 1SmartBead Technologies Limited, Babraham Hall, Babraham, Cambridge CB2 4AT, United Kingdom. jsmith@smartbead.com

Annals of the New York Academy of Sciences
|July 15, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and acceptability of Hanen<sup>®</sup> More Than Words program for migrant Australian families.

International journal of speech-language pathology·2026
Same author

"I Just Feel Like the Teacher Understood Me, and She Knew What I Needed": School Experiences of Autistic Students from Diverse Backgrounds.

Autism & developmental language impairments·2025
Same author

Antibody drug conjugates of echinomycin-based payloads.

Bioorganic & medicinal chemistry·2025
Same author

Accuracy of a 2-minute eye-tracking assessment to differentiate young children with and without autism.

Molecular autism·2025
Same author

'I'm sick of being the problem': Autistic mothers' experiences of interacting with schools for their autistic children.

Autism : the international journal of research and practice·2024
Same author

Autistic and autism community perspectives on infant and family support in the first two years of life: Findings from a community consultation survey.

Autism : the international journal of research and practice·2024

SmartBead Technologies developed the UltraPlex ANA Profile, a multiplexed immunofluorescence assay for simultaneously detecting nine antinuclear antibodies (ANA). This automated assay offers equivalent performance to gold standards with reduced labor and reagent use.

Area of Science:

  • * Clinical chemistry
  • * Immunology
  • * Biotechnology

Background:

  • * Antinuclear antibodies (ANA) are critical biomarkers for diagnosing autoimmune diseases.
  • * Traditional methods for ANA detection are often labor-intensive and time-consuming.
  • * Multiplex assays offer a more efficient approach to detecting multiple autoantibodies concurrently.

Purpose of the Study:

  • * To introduce and evaluate the UltraPlex ANA Profile, a novel multiplexed immunofluorescence assay.
  • * To assess the assay's ability to simultaneously determine nine key antinuclear antibodies.
  • * To demonstrate the automation and efficiency of the UltraPlex assay platform.

Main Methods:

  • * Development of a multiplexed immunofluorescence assay using bar-coded microparticles for analyte tracking.

Related Experiment Videos

  • * Simultaneous detection of nine ANA markers (Jo-1, Scl-70, Sm, SmRNP, SSA, SSB, U1RNP, Centromere B, dsDNA) and a control.
  • * Full automation of assay procedures including dilutions, reagent additions, washes, and incubations using a Perkin-Elmer multiprobe II system.
  • * Results interpretation via an automated UltraPlex plate reader.

    • Main Results:

    • * The UltraPlex ANA Profile successfully screened commercially available ANA-positive sera and negative control samples.
    • * The assay simultaneously detected nine distinct antinuclear antibodies in a multiplex format.
    • * Performance was found to be equivalent to existing gold-standard methods for ANA detection.

    Conclusions:

    • * The UltraPlex ANA Profile is a fully automated, multiplexed immunoassay for simultaneous ANA detection.
    • * The assay significantly reduces labor and reagent requirements compared to traditional methods.
    • * This technology provides an efficient and accurate tool for screening antinuclear antibodies.